We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

The next generation of genetically modified (GM) plants may make products headed for the pharmacy shelves. Researchers and biotech companies have begun engineering plants to produce a wide variety of pharmaceuticals such as edible vaccines, therapeutic proteins and plant-produced antibodies.

This article from the Pew Initiative on Food and Biotechnology describes how far the technology has progressed, and looks into the pros and cons of so-called 'pharming'.

While the technology's developers hope GM plants will provide a cheaper way to produce drugs, consumer advocates argue that current regulatory system isn't up to the challenge of plant-based pharmaceuticals, and environmentalists are concerned that the proteins produced could accidentally make their way into the food supply.

Link to full AgBiotech Buzz article

Related topics